使用通用名阿仑膦酸盐治疗骨质疏松症。 - Suppr | 超能文献

Use of generic alendronate in the treatment of osteoporosis.

出版信息

S Afr Med J. 2006 Aug;96(8):696-7.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Use of generic alendronate in the treatment of osteoporosis.使用通用名阿仑膦酸盐治疗骨质疏松症。

S Afr Med J. 2006 Aug;96(8):696-7.

2

NOFSA statement on generic bisphosphonates.国家骨质疏松基金会关于通用双膦酸盐的声明。

S Afr Med J. 2006 Sep;96(9):758-60.

3

Generic alendronate in the treatment of osteoporosis.普通阿仑膦酸钠治疗骨质疏松症

S Afr Med J. 2006 Oct;96(10):1008-10.

4

[Cost effective osteoporosis therapy. Alendronate is also immediately available as a generic drug].具有成本效益的骨质疏松症治疗。阿仑膦酸盐也可作为仿制药立即获得。

MMW Fortschr Med. 2005 Dec 8;147(49-50):74-5.

5

The comparative gastrointestinal tolerability of proprietary versus generic alendronate in patients treated for primary osteoporosis.用于原发性骨质疏松症治疗的专利与通用阿仑膦酸钠的胃肠道耐受性比较。

Bone. 2012 Oct;51(4):637-42. doi: 10.1016/j.bone.2012.07.009. Epub 2012 Jul 24.

6

NOFSA statement on generic bisphosphonates.国家骨质疏松基金会关于通用双膦酸盐的声明。

S Afr Med J. 2006 Dec;96(12):1214.

7

Comparing tolerability and efficacy of generic versus brand alendronate: a randomized clinical study in postmenopausal women with a recent fracture.比较普通阿仑膦酸钠与原研阿仑膦酸钠的耐受性和疗效：一项针对近期骨折的绝经后女性的随机临床研究。

PLoS One. 2013 Oct 21;8(10):e78153. doi: 10.1371/journal.pone.0078153. eCollection 2013.

8

[Evidence of alendronate treatment for osteoporosis].[阿仑膦酸盐治疗骨质疏松症的证据]

Nihon Rinsho. 2007 Nov 28;65 Suppl 9:337-43.

9

[Postmenopausal osteoporosis. Bisphosphonates are not all equal].[绝经后骨质疏松症。双膦酸盐并非完全相同]

MMW Fortschr Med. 2009 Mar 12;151(11):46-7.

10

[When should bisphosphonate treatment be discontinued?].[双膦酸盐治疗应在何时停药？]

Tidsskr Nor Laegeforen. 2012 Aug 7;132(14):1630-2. doi: 10.4045/tidsskr.11.0788.

引用本文的文献

1

Adverse events, bone mineral density and discontinuation associated with generic alendronate among postmenopausal women previously tolerant of brand alendronate: a retrospective cohort study.在绝经后妇女中，先前耐受品牌阿仑膦酸钠的情况下，与通用阿仑膦酸钠相关的不良反应、骨密度和停药：一项回顾性队列研究。

BMC Musculoskelet Disord. 2010 Apr 14;11:68. doi: 10.1186/1471-2474-11-68.